|
|
|
Insider
Information: |
Mccracken Joseph S |
Relationship: |
Director |
City: |
Blackrock |
State: |
L2 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
206,558 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$815,896 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
206,558 |
|
|
Total
Value |
$815,896 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
3
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-30.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nexvet Biopharma Plc |
NVET |
Director |
2017-07-31 |
0 |
|
0 |
Premium* |
|
Savara Inc |
SVRA |
Director |
2023-12-14 |
190,837 |
|
0 |
Premium* |
|
Lumos Pharma Inc |
LUMO |
Director |
2022-11-16 |
15,721 |
2020-04-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LUMO |
Lumos Pharma Inc |
Director |
|
2020-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
709 |
709 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
367 |
1,076 |
0 |
- |
|
LUMO |
Lumos Pharma Inc |
Director |
|
2021-08-11 |
4 |
B |
$7.55 |
$56,406 |
D/D |
7,475 |
8,551 |
2.39 |
% |
|
LUMO |
Lumos Pharma Inc |
Director |
|
2022-08-25 |
4 |
B |
$8.60 |
$27,262 |
D/D |
3,170 |
11,721 |
2.39 |
% |
|
LUMO |
Lumos Pharma Inc |
Director |
|
2022-11-16 |
4 |
B |
$5.03 |
$20,120 |
D/D |
4,000 |
15,721 |
2.39 |
% |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2015-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,400 |
|
- |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2015-05-18 |
4 |
OE |
$0.13 |
$175 |
D/D |
1,400 |
3,800 |
0 |
- |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2015-06-30 |
4 |
OE |
$0.13 |
$175 |
D/D |
1,400 |
5,200 |
0 |
- |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2015-09-30 |
4 |
OE |
$0.13 |
$63 |
D/D |
500 |
5,700 |
0 |
- |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2015-12-31 |
4 |
OE |
$0.13 |
$63 |
D/D |
500 |
6,200 |
0 |
- |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2016-03-31 |
4 |
OE |
$0.13 |
$63 |
D/D |
500 |
6,700 |
0 |
- |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2016-06-30 |
4 |
OE |
$0.13 |
$63 |
D/D |
500 |
7,200 |
0 |
- |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2016-07-01 |
4 |
OE |
$0.13 |
$450 |
D/D |
3,600 |
10,800 |
0 |
- |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2016-09-30 |
4 |
OE |
$0.13 |
$63 |
D/D |
500 |
11,300 |
0 |
- |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2016-12-31 |
4 |
OE |
$0.13 |
$63 |
D/D |
500 |
11,800 |
0 |
- |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2017-03-31 |
4 |
OE |
$0.13 |
$63 |
D/D |
500 |
12,300 |
0 |
- |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2017-06-30 |
4 |
OE |
$0.13 |
$63 |
D/D |
500 |
12,800 |
0 |
- |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2017-07-01 |
4 |
OE |
$0.13 |
$450 |
D/D |
3,600 |
16,400 |
0 |
- |
|
NVET |
Nexvet Biopharma Plc |
Director |
|
2017-07-31 |
4 |
D |
$6.72 |
$110,208 |
D/D |
(16,400) |
0 |
0 |
- |
|
SVRA |
Savara Inc |
Director |
|
2017-04-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,616 |
|
- |
|
SVRA |
Savara Inc |
Director |
|
2017-06-07 |
4 |
B |
$4.75 |
$248,188 |
D/D |
52,250 |
59,866 |
2.39 |
- |
|
SVRA |
Savara Inc |
Director |
|
2019-07-05 |
4 |
OE |
$0.82 |
$44,637 |
D/D |
39,506 |
99,372 |
0 |
- |
|
SVRA |
Savara Inc |
Director |
|
2021-03-15 |
4 |
B |
$1.45 |
$99,999 |
D/D |
68,965 |
168,337 |
2.39 |
% |
|
SVRA |
Savara Inc |
Director |
|
2023-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
190,837 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|